BVR Briefing – The Real Story of COVID-19 For Valuation and Litigation Experts
Table of Contents
About the Author
Part 1. Getting to the Truth about COVID-19
1-1. Probability versus Statistics
1-2. Origin of the Virus
Known or Knowable?
Death Counts and Death Certificates
1-4. To Mask or Not to Mask
1-5. All Healthcare is Local
What Happened in New York?
What Happened in South Korea?
1-6. Will Testing Save Us?
Testing Accuracy and Inaccuracy: Let's Do the Math
What is 'Herd Immunity'?
1-7. Where Do We Go From Here?
All Healthcare is Local
Uneven Access to Healthcare
Do More Doctors Equal Better COVID-19 Outcomes?
Is Healthcare Spending Positively Correlated With Pandemic Control?
1-8. Forecasting Cash Flow
Unemployment and Decreased Consumer Spending
Insurers and Premiums
Loss of Healthcare Coverage
Billing 'Out-of-Network' and Private Equity
Increase in State Income Taxes
Nursing Home Industry
Closure of Smaller Hospitals and/or Consolidation With Larger Health Systems
Planning - or Speculating - About the Future
1-9. What Do I Tell My Clients - Business, Valuation or Otherwise?
June 15, 2020
July 4, 2020
Part 2. Healthcare Valuation in the Coronavirus Era: That Was Then, This Is Now
2-2. Data Sources
2-3. Statistics versus Probability
2-4. World Health Organization
2-5. A Look at the Science of COVID-19
2-6. Structural Issues in Addressing the Pandemic
2-7. All Healthcare is Local
2-10. Prognostications on Valuation